Mostrar el registro sencillo del ítem

dc.contributorFacultad de Ciencias Biologicas y Ambientaleses_ES
dc.contributor.authorLópez Ferreras, Lorena 
dc.contributor.authorMartínez-García, Nicole 
dc.contributor.authorMaeso Alonso, Laura 
dc.contributor.authorMartín López, Marta
dc.contributor.authorDíez Matilla, Ángela
dc.contributor.authorVilloch-Fernández, Javier
dc.contributor.authorAlonso-Olivares, Hugo
dc.contributor.authorMarqués Martínez, Margarita 
dc.contributor.authorMarín Vieira, María Carmen 
dc.contributor.otherBioquimica y Biologia Moleculares_ES
dc.date2021-06-25
dc.date.accessioned2024-01-18T11:59:12Z
dc.date.available2024-01-18T11:59:12Z
dc.identifier.citationLópez-Ferreras, L., Martínez-García, N., Maeso-Alonso, L., Martín-López, M., Díez-Matilla, Á., Villoch-Fernandez, J., Alonso-Olivares, H., Marques, M. M., & Marin, M. C. (2021). Deciphering the nature of trp73 isoforms in mouse embryonic stem cell models: Generation of isoform-specific deficient cell lines using the crispr/cas9 gene editing system. Cancers, 13(13), Article e3182. https://doi.org/10.3390/CANCERS13133182es_ES
dc.identifier.otherhttps://www.mdpi.com/2072-6694/13/13/3182es_ES
dc.identifier.urihttps://hdl.handle.net/10612/17669
dc.descriptionThis article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshopes_ES
dc.description.abstract[EN] The p53 family has been widely studied for its role in various physiological and pathological processes. Imbalance of p53 family proteins may contribute to developmental abnormalities and pathologies in humans. This family exerts its functions through a profusion of isoforms that are generated by different promoter usage and alternative splicing in a cell type dependent manner. In particular, the Trp73 gene gives rise to TA and DN-p73 isoforms that confer p73 a dual nature. The biological relevance of p73 does not only rely on its tumor suppression effects, but on its pivotal role in several developmental processes. Therefore, the generation of cellular models that allow the study of the individual isoforms in a physiological context is of great biomedical relevance. We generated specific TA and DN-p73-deficient mouse embryonic stem cell lines using the CRISPR/Cas9 gene editing system and validated them as physiological bona fide p73-isoform knockout models. Global gene expression analysis revealed isoform-specific alterations of distinctive transcriptional networks. Elimination of TA or DN-p73 is compatible with pluripotency but prompts naïve pluripotent stem cell transition into the primed state, compromising adequate lineage differentiation, thus suggesting that differential expression of p73 isoforms acts as a rheostat during early cell fate determinationes_ES
dc.languageenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBioquímicaes_ES
dc.subjectBiotecnologíaes_ES
dc.subjectGenéticaes_ES
dc.subject.otherp73 isoformses_ES
dc.subject.otherTAp73es_ES
dc.subject.otherDNp73es_ES
dc.subject.otherMouse embryonic stem cells (mESC)es_ES
dc.subject.otherGene editinges_ES
dc.subject.otherPluripotencyes_ES
dc.subject.otherDifferentiationes_ES
dc.subject.otherCell fatees_ES
dc.subject.otherSelf-renewales_ES
dc.subject.otherCRISPR/Cas9es_ES
dc.titleDeciphering the Nature of Trp73 Isoforms in Mouse Embryonic Stem Cell Models: Generation of Isoform-Specific Deficient Cell Lines Using the CRISPR/Cas9 Gene Editing Systemes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.3390/cancers13133182
dc.description.peerreviewedSIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i/PID2019-105169RB-I00/ES/FUNCION DE P73 EN EL ADHESOMA CELULAR: IMPLICACIONES EN MORFOGENESIS VASCULAR, ANGIOGENESIS Y CANCERes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn2072-6694
dc.journal.titleCancerses_ES
dc.volume.number13es_ES
dc.issue.number13es_ES
dc.page.initial3182es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.unesco2410.07 Genética Humanaes_ES
dc.subject.unesco2415 Biología Moleculares_ES
dc.subject.unesco3201.01 Oncologíaes_ES
dc.subject.unesco2409.02 Ingeniería Genéticaes_ES
dc.subject.unesco2407 Biología Celulares_ES
dc.description.projectThis work was supported by Grants PID2019-105169RB-I00 from Spanish Ministerio de Ciencia e Innovación cofinanced by FEDER funds (to M.C.M.) and LE021P17 from Junta de Castilla y Leon. L.L.-F. was a holder of a postdoctoral contract “Juan de de la Cierva-Incorporacion” from Ministerio de Ciencia e Innovación. N.M.-G. and H.A.-O. are supported by a predoctoral scholarship from the Asociación Española contra el Cáncer (AECC). M.M.-L. was a recipient of a Torres Quevedo contract from Ministerio de Ciencia e Innovación at Biomar Microbial Technologies. Á.D.-M., J.V.-F. and L.M.-A. are funded by Junta de Castilla y Leónes_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional